Although some authors have reported that ROR2 expression might serve as a convenient prognostic biomarker and a potential therapeutic target for malignant tumors21, 22, 23, 24, they may have ignored ROR2 protein expression in tumor stromal cells. The gene discussed is ROR2; the disease is neoplasm.